These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3393731)

  • 1. Stereoselective oxidation and plasma protein binding of nilvadipine, a new dihydropyridine calcium antagonist, in man.
    Niwa T; Tokuma Y; Nakagawa K; Noguchi H; Yamazoe Y; Kato R
    Res Commun Chem Pathol Pharmacol; 1988 May; 60(2):161-72. PubMed ID: 3393731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective oxidation of nilvadipine, a new dihydropyridine calcium antagonist, in rat and dog liver.
    Niwa T; Tokuma Y; Nakagawa K; Noguchi H
    Drug Metab Dispos; 1989; 17(1):64-8. PubMed ID: 2566472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidation of nilvadipine, a new dihydropyridine calcium antagonist, to the corresponding pyridine by rat liver microsomes.
    Niwa T; Tokuma Y; Noguchi H
    Xenobiotica; 1988 Feb; 18(2):217-24. PubMed ID: 3376493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma protein binding of nilvadipine, a new dihydropyridine calcium antagonist, in man and dog.
    Niwa T; Tokuma Y; Noguchi H
    Res Commun Chem Pathol Pharmacol; 1987 Jan; 55(1):75-88. PubMed ID: 3563108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective disposition of nilvadipine, a new dihydropyridine calcium antagonist, in the rat and dog.
    Tokuma Y; Fujiwara T; Niwa T; Hashimoto T; Noguchi H
    Res Commun Chem Pathol Pharmacol; 1989 Feb; 63(2):249-62. PubMed ID: 2711027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs.
    Terashita S; Tokuma Y; Fujiwara T; Shiokawa Y; Okumura K; Noguchi H
    Xenobiotica; 1987 Dec; 17(12):1415-25. PubMed ID: 3439192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of (+)- and (-)-nilvadipine after oral dosing with racemic (+)-nilvadipine in man.
    Tokuma Y; Fujiwara T; Noguchi H
    Res Commun Chem Pathol Pharmacol; 1987 Aug; 57(2):229-37. PubMed ID: 3659571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of the new calcium entry blocker nilvadipine to rat aortic and guinea pig left ventricular membranes.
    Matsuo M; Koibuchi Y; Tomoi M; Ono T; Shibayama F; Ohtsuka M
    Arzneimittelforschung; 1989 May; 39(5):576-9. PubMed ID: 2757673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective metabolism of felodipine in liver microsomes from rat, dog, and human.
    Eriksson UG; Lundahl J; Bäärnhielm C; Regårdh CG
    Drug Metab Dispos; 1991; 19(5):889-94. PubMed ID: 1686232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic hemorheological effects of the calcium antagonist nilvadipine in essential hypertension.
    Tsuda Y; Satoh K; Kitadai M; Izumi Y; Takahashi T
    Arzneimittelforschung; 1997 Aug; 47(8):900-4. PubMed ID: 9296274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol.
    Obach RS
    Drug Metab Dispos; 1997 Dec; 25(12):1359-69. PubMed ID: 9394025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of (+)- and (-)-nilvadipine in human plasma using chiral stationary-phase liquid chromatography and gas chromatography-mass spectrometry, and a preliminary pharmacokinetic study in humans.
    Tokuma Y; Fujiwara T; Noguchi H
    J Pharm Sci; 1987 Apr; 76(4):310-3. PubMed ID: 3598890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oxidation of low-density lipoprotein on drug binding affinity studied by high performance frontal analysis-capillary electrophoresis.
    Kuroda Y; Cao B; Shibukawa A; Nakagawa T
    Electrophoresis; 2001 Oct; 22(16):3401-7. PubMed ID: 11669517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in the metabolism and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats.
    Terashita S; Tokuma Y; Sekiguchi M; Noguchi H
    Xenobiotica; 1989 Nov; 19(11):1221-9. PubMed ID: 2618076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonlinear stereoselective pharmacokinetics of ketoconazole in rat after administration of racemate.
    Hamdy DA; Brocks DR
    Chirality; 2009 Jul; 21(7):704-12. PubMed ID: 18988259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nilvadipine, a calcium antagonist, on rabbit ocular circulation and optic nerve head circulation in NTG subjects.
    Tomita K; Araie M; Tamaki Y; Nagahara M; Sugiyama T
    Invest Ophthalmol Vis Sci; 1999 May; 40(6):1144-51. PubMed ID: 10235547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective metabolism of tazofelone, an anti-inflammatory bowel disease agent, in rats and dogs and in human liver microsomes.
    Clay MP; Hanssen BR; Surapaneni SS; Lindstrom TD
    Chirality; 1999; 11(3):233-40. PubMed ID: 10079502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex difference in the stereoselective metabolism of a new dihydropyridine calcium channel blocker, in rat studies in vivo and in vitro.
    Takayama F; Saito K; Ishii Y; Shiratori K; Ohtawa M
    Xenobiotica; 1991 May; 21(5):557-68. PubMed ID: 1949888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantioselective distribution of verapamil and norverapamil into human and rat erythrocytes: the role of plasma protein binding.
    Robinson MA; Mehvar R
    Biopharm Drug Dispos; 1996 Oct; 17(7):577-87. PubMed ID: 8894116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.